Special Drug Use Surveillance of LIXIANA Tablet - Long-term use in patients with venous thromboembolism -
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Edoxaban (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thrombosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms ETNA-VTE-Japan
- Sponsors Daiichi Sankyo Company
- 02 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 13 Apr 2015 Status changed from not yet recruiting to recruiting as reported by UMIN record.
- 04 Feb 2015 New trial record